Former Eli Lilly Sales Representative Files Lawsuit Over Alleged Wrongful Termination
A former sales representative has filed a lawsuit against Eli Lilly (LLY), alleging wrongful termination. The plaintiff claims she was fired in retaliation for raising concerns regarding the company's marketing practices for its GLP-1 therapy, Mounjaro. The lawsuit alleges that the Indiana-based pharmaceutical giant was promoting Mounjaro for weight loss purposes prior to obtaining the necessary regulatory approvals for that specific indication. This legal action highlights potential compliance and regulatory risks surrounding the promotion of high-demand metabolic drugs.
Tickers: $LLY
Topics: GLP-1 drugs off-label promotion regulatory compliance wrongful termination
Read the full article at Seeking Alpha
Part of the story Lilly sued over alleged firing of sales rep for complaints about Mounjaro misbranding (2 articles)